With an income increase of 51.93% in the second quarter 2020, year on year to cumulative value of $17 million, and with 100 employees, Principia Biopharma Inc 's income per employee grew on trailing twelve month basis to $ 173,820. The income per employee at Principia Biopharma Inc ' was above the company average.
The Healthcare sector has seen Principia Biopharma Inc achieved the highest income per employee. While income per employee remained unchanged compared to the previous quarter at no. .

What is Income per Employee Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Net Income per Employee▼

None ▼

Net Income per Employee▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PRNB Net Income per Employee	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter	(Dec 31 2019) IV. Quarter	(Sep 30 2019) III. Quarter	(Jun 30 2019) II. Quarter
Y / Y Net Income Change	51.93 %	-	207.86 %	-	-
Net Income per Employee (TTM) $	173,820	136,870	-	-194,910	94,880
PRNB's Total Ranking	#	#	# 2804	# 3679	# 739
Seq. Net Income Change	-	-	-	-	-

PRNB Company Profile >> Back to PRNB Efficiency Comparisons >> Compare PRNB Net Income per Employee to its Competitors

PRNB Net Income per Employee Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	#
Healthcare Sector	#
Overall Market	#

Net Income per Employee Statistics
High	Average	Low
$ 94,880	$ -8,300	$ -194,910
(Jun 30 2019)		(Sep 30 2019)

Companies with similar Income per Employee for 12 month ending Jun 30 2020, within Healthcare Sector	Income per Employee	Income 12 month ending Jun 30 2020	Number of Employees Jun 30 2020
Bio rad Laboratories Inc	261,343.76	$ 1,947.011 Million	7,450
Exelixis Inc	245,534.44	$ 281.628 Million	1,147
Catalyst Pharmaceuticals Inc	229,482.93	$ 41.766 Million	182
Alexion Pharmaceuticals Inc	220,510.82	$ 846.100 Million	3,837
Vanda Pharmaceuticals Inc	213,581.61	$ 113.839 Million	533
Alpha Pro Tech Ltd	208,626.02	$ 25.661 Million	123
Regeneron Pharmaceuticals Inc	193,608.05	$ 2,983.500 Million	15,410
Pfizer Inc	189,346.67	$ 14,201.000 Million	75,000
Emergent Biosolutions Inc	189,111.11	$ 170.200 Million	900
Supernus Pharmaceuticals inc	181,248.47	$ 118.174 Million	652
Abiomed Inc	158,674.00	$ 158.674 Million	1,000
Corcept Therapeutics Inc	156,319.18	$ 114.113 Million	730
Merck and Co Inc	140,000.00	$ 10,500.000 Million	75,000
Siga Technologies Inc	128,248.92	$ 6.284 Million	49
Abbvie Inc	122,035.09	$ 6,956.000 Million	57,000
Avadel Pharmaceuticals Plc	119,519.48	$ 18.406 Million	154
Eli Lilly And Company	112,362.00	$ 5,618.100 Million	50,000
Ionis Pharmaceuticals Inc	112,072.04	$ 157.125 Million	1,402
Zoetis Inc	111,448.28	$ 1,616.000 Million	14,500
Johnson and Johnson	107,848.01	$ 15,185.000 Million	140,800
Neurocrine Biosciences Inc	102,394.50	$ 204.789 Million	2,000
Nrc Health	101,644.26	$ 36.287 Million	357
Masimo Corp	101,015.45	$ 222.234 Million	2,200
Crispr Therapeutics Ag	97,402.99	$ 19.578 Million	201
Zomedica Corp	95,470.40	$ 13.461 Million	141
Co diagnostics Inc	90,930.82	$ 10.457 Million	115

Date modified: 2026-09-18T13:11:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.